Free Trial

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Short Interest Update

Cross Country Healthcare logo with Business Services background

Cross Country Healthcare, Inc. (NASDAQ:CCRN - Get Free Report) saw a large increase in short interest in August. As of August 31st, there was short interest totalling 4,080,000 shares, an increase of 5.4% from the August 15th total of 3,870,000 shares. Based on an average daily volume of 439,500 shares, the short-interest ratio is presently 9.3 days. Approximately 12.8% of the company's shares are sold short.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CCRN shares. Barrington Research lowered their price objective on Cross Country Healthcare from $21.00 to $19.00 and set an "outperform" rating for the company in a research note on Thursday, August 8th. Truist Financial increased their price objective on Cross Country Healthcare from $16.00 to $17.00 and gave the stock a "hold" rating in a research note on Thursday, August 1st. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $19.60.

Read Our Latest Stock Analysis on Cross Country Healthcare

Cross Country Healthcare Stock Up 1.3 %

Cross Country Healthcare stock traded up $0.19 during mid-day trading on Tuesday, reaching $14.37. 408,330 shares of the company's stock were exchanged, compared to its average volume of 435,579. The business's fifty day simple moving average is $15.00 and its 200 day simple moving average is $15.79. The firm has a market capitalization of $499.70 million, a PE ratio of 11.12, a P/E/G ratio of 2.61 and a beta of 0.63. Cross Country Healthcare has a one year low of $12.87 and a one year high of $25.76.


Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The business services provider reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.04). The company had revenue of $339.77 million during the quarter, compared to analysts' expectations of $334.75 million. Cross Country Healthcare had a net margin of 0.54% and a return on equity of 7.29%. Cross Country Healthcare's revenue for the quarter was down 37.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.69 earnings per share. On average, sell-side analysts forecast that Cross Country Healthcare will post 0.52 earnings per share for the current year.

Insider Activity at Cross Country Healthcare

In related news, VP Cynthia Ann Grieco sold 1,945 shares of the company's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $17.21, for a total transaction of $33,473.45. Following the transaction, the vice president now directly owns 7,605 shares of the company's stock, valued at approximately $130,882.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, VP Cynthia Ann Grieco sold 1,945 shares of the company's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $17.21, for a total transaction of $33,473.45. Following the transaction, the vice president now directly owns 7,605 shares of the company's stock, valued at approximately $130,882.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Karen Mote sold 13,829 shares of the company's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $17.08, for a total value of $236,199.32. Following the transaction, the insider now directly owns 24,696 shares in the company, valued at $421,807.68. The disclosure for this sale can be found here. 4.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Cross Country Healthcare

Several hedge funds have recently made changes to their positions in CCRN. nVerses Capital LLC purchased a new position in Cross Country Healthcare during the second quarter worth about $50,000. GAMMA Investing LLC grew its position in Cross Country Healthcare by 622.4% during the second quarter. GAMMA Investing LLC now owns 5,678 shares of the business services provider's stock worth $79,000 after buying an additional 4,892 shares in the last quarter. Denali Advisors LLC grew its position in Cross Country Healthcare by 3,885.5% during the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider's stock worth $103,000 after buying an additional 5,362 shares in the last quarter. EMC Capital Management purchased a new position in Cross Country Healthcare during the first quarter worth about $155,000. Finally, Versor Investments LP grew its position in Cross Country Healthcare by 20.4% during the second quarter. Versor Investments LP now owns 12,400 shares of the business services provider's stock worth $172,000 after buying an additional 2,100 shares in the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Read More

→ The election trade you can't lose (From Investors Alley) (Ad)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines